Biocon Biologics clears path for Stelara Biosimilar in major markets 0 29.08.2024 08:21 Thehindubusinessline.com Biocon Biologics CEO Shreehas Tambe says Bmab 1200 will strengthen its immunology franchise, enabling it to offer an affordable and effective treatment option for patients impacted by autoimmune diseases Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
